Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIO-RAD LABORATORIES, INC.BIO BIO.B · Entity 2247 | EVP, Global Supply Chain | September 04, 2026 | September 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIO-RAD LABORATORIES, INC.
Report date September 04, 2026 · Filed September 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 3,345.12 |
Reported balance
After 2026-09-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-05 · Exercise / conversion · Acquired 1,027 · Balance 3,345.12 F1: Shares of Class A common stock acquired on the vesting of restricted stock units. F2: Includes 51.2870 and 33.9860 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2026 and 06/30/2026, respectively. |
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 3,016.12 |
Reported balance
After 2026-09-05 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-09-05 · Tax withholding · Disposed 329 · Balance 3,016.12 |
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 3,880.12 |
Reported balance
After 2026-09-06 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-09-06 · Exercise / conversion · Acquired 864 · Balance 3,880.12 F1: Shares of Class A common stock acquired on the vesting of restricted stock units. |
| Bio-Rad A Common StockSEC Table I · non-derivative | Direct | 3,603.12 |
Reported balance
After 2026-09-06 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-09-06 · Tax withholding · Disposed 277 · Balance 3,603.12 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 4,026 |
Reported balance
After 2026-09-04 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-04 · Grant · Acquired 4,026 · Balance 4,026 F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 3,083 |
Reported balance
After 2026-09-05 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-05 · Exercise / conversion · Disposed 1,027 · Balance 3,083 F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,728 |
Reported balance
After 2026-09-06 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-06 · Exercise / conversion · Disposed 864 · Balance 1,728 F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Includes 51.2870 and 33.9860 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2026 and 06/30/2026, respectively.
F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter.
F5: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 06, 2026 Filed Sep 9, 2026 22:46 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 864 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001993147-26-000002 · wk-form4_1788993983.xml · derivative · entry 7 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,728 Underlying: Bio-Rad A Common Stock · 864 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F5 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:46 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 277 | $386.11 | $106,952.47 |
DisclosureSEC source: 0001993147-26-000002 · wk-form4_1788993983.xml · nonDerivative · entry 4 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,603.12 Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:46 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 864 | $0.00 | $0.00 |
DisclosureSEC source: 0001993147-26-000002 · wk-form4_1788993983.xml · nonDerivative · entry 3 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,880.12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:46 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 1,027 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001993147-26-000002 · wk-form4_1788993983.xml · derivative · entry 6 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,083 Underlying: Bio-Rad A Common Stock · 1,027 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F5 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:46 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 329 | $386.11 | $127,030.19 |
DisclosureSEC source: 0001993147-26-000002 · wk-form4_1788993983.xml · nonDerivative · entry 2 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,016.12 Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:46 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 1,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001993147-26-000002 · wk-form4_1788993983.xml · nonDerivative · entry 1 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,345.12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 51.2870 and 33.9860 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2026 and 06/30/2026, respectively. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 22:46 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | GrantRestricted Stock Units · Derivative | 4,026 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001993147-26-000002 · wk-form4_1788993983.xml · derivative · entry 5 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,026 Underlying: Bio-Rad A Common Stock · 4,026 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. F4 · derivative.expiration_date: The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter. Read SEC document |
| October 20, 2025 Filed Oct 21, 2025 20:42 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 1,044 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001993147-25-000006 · wk-form4_1761079318.xml · derivative · entry 3 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,088 Underlying: Bio-Rad A Common Stock · 1,044 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F3 · derivative.exercise_date: On October 20, 2023, the reporting person was granted 4,176 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On October 20, 2023, the reporting person was granted 4,176 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| October 20, 2025 Filed Oct 21, 2025 20:42 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 335 | $321.90 | $107,836.50 |
DisclosureSEC source: 0001993147-25-000006 · wk-form4_1761079318.xml · nonDerivative · entry 2 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,232.847 Read SEC document |
| October 20, 2025 Filed Oct 21, 2025 20:42 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 1,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001993147-25-000006 · wk-form4_1761079318.xml · nonDerivative · entry 1 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,567.847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:24 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 864 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001993147-25-000004 · wk-form4_1757449440.xml · derivative · entry 4 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,592 Underlying: Bio-Rad A Common Stock · 864 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:24 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 277 | $295.43 | $81,834.11 |
DisclosureSEC source: 0001993147-25-000004 · wk-form4_1757449440.xml · nonDerivative · entry 2 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,523.847 Read SEC document |
| September 06, 2025 Filed Sep 9, 2025 20:24 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 864 | $0.00 | $0.00 |
DisclosureSEC source: 0001993147-25-000004 · wk-form4_1757449440.xml · nonDerivative · entry 1 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800.847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 56.9880 and 26.7190 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2025 and 06/30/2025, respectively. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:24 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | GrantRestricted Stock Units · Derivative | 4,110 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001993147-25-000004 · wk-form4_1757449440.xml · derivative · entry 3 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,110 Underlying: Bio-Rad A Common Stock · 4,110 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:51 UTC | BIO-RAD LABORATORIES, INC. BIO BIO.B · Entity 2247 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 2,918 | $0.00 Strike: $256.45 | $0.00 |
DisclosureSEC source: 0001062993-25-004591 · form4.xml · derivative · entry 1 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,918 Underlying: Bio-Rad A Common Stock · 2,918 shares Expires 2035-03-03 F1 · derivative.exercise_date: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| October 20, 2024 Filed Oct 22, 2024 20:30 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionRestricted Stock Units · Derivative | 1,044 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-017850 · form4.xml · derivative · entry 3 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,132 Underlying: Bio-Rad A Common Stock · 1,044 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On October 20, 2023, the reporting person was granted 4,176 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On October 20, 2023, the reporting person was granted 4,176 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| October 20, 2024 Filed Oct 22, 2024 20:30 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Tax withholdingBio-Rad A Common Stock | 335 | $346.37 | $116,033.95 |
DisclosureSEC source: 0001062993-24-017850 · form4.xml · nonDerivative · entry 2 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 853.14 Read SEC document |
| October 20, 2024 Filed Oct 22, 2024 20:30 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | Exercise / conversionBio-Rad A Common Stock | 1,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-017850 · form4.xml · nonDerivative · entry 1 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188.14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 49.0480, 41.3870 and 33.7050 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/2023, 03/31/2024 and 06/30/2024, respectively. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 18:25 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | GrantRestricted Stock Units · Derivative | 3,456 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016392 · form4.xml · derivative · entry 1 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,456 Underlying: Bio-Rad A Common Stock · 3,456 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 16:27 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,535 | $0.00 Strike: $343.76 | $0.00 |
DisclosureSEC source: 0001062993-24-006217 · form4.xml · derivative · entry 2 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,535 Underlying: Bio-Rad A Common Stock · 3,535 shares Expires 2034-03-08 F2 · derivative.exercise_date: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| October 20, 2023 Filed Oct 24, 2023 01:10 UTC | BIO-RAD LABORATORIES, INC. BIO BIOB · Entity 2247 | GrantRestricted Stock Units · Derivative | 4,176 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-019632 · form4.xml · derivative · entry 1 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,176 Underlying: Bio-Rad A Common Stock · 4,176 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.